FDA Issued Clinical Trial Guidance for COVID-19
FDA issued clinical trial guidance, though ‘Unavoidable’ protocol deviations are anticipated The U.S. Food and Drug Administration (FDA) issued clinical trial guidance last week for industry, investigators, and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic. The FDA recognizes that the COVID-19…